阻断IL-4/IL-13轴与JAK/STAT通路在亚托匹性皮肤炎:我们如何选择?
Laura Calabrese1,2, Martina D'Onghia1, Laura Lazzeri1
1Dermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.
Journal of personalized medicine
|July 27, 2024
概括
亚托邦性皮肤炎 (AD) 是一种复杂的皮肤疾病,具有多种患者表型. 新的全身疗法,包括生物药物和JAK抑制剂,提供有针对性的治疗选择,但选择正确的需要仔细考虑个体患者的因素.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托邦性皮肤炎 (AD) 是一种慢性,免疫媒介性皮肤疾病,其病因复杂.
- 传统上被视为一种2型免疫驱动的疾病,AD现在被认为是高度异质的,具有不同的临床和分子表型.
- 对于中度至重度的AD,以前存在着有限的全身治疗选择,主要是传统的免疫抑制剂.
研究的目的:
- 审查阿托皮性皮肤炎的临床和分子异质性.
- 探索影响中度至重度AD治疗决策的因素.
- 为皮肤科医生提供指导,根据患者特定的参数选择最佳疗法.
主要方法:
- 关于最近在亚托皮性皮肤炎研究方面的进展的文献综述.
- 对阿尔茨海默病的现有和新兴系统疗法的分析.
- 检查患者分层的临床和分子参数.
主要成果:
- 对于中度至重度AD的治疗场景已经随着新的生物药物和小分子而显著扩大.
- 目前的全身治疗主要针对IL-4/13通路 (例如,dupilumab,tralokinumab) 或JAK/STAT通路 (例如,abrocitinib,upadacitinib).
- 针对IL-4/13和JAK/STAT的向疗法都显示出强大的疗效,这对临床医生来说是一个选择挑战.
结论:
- 亚托邦性皮肤炎的异质性需要个性化治疗方法.
- 诸如AD表型,并发症,患者年龄和偏好等因素对于指导治疗选择至关重要.
- 在IL-4/13轴和JAK/STAT通路抑制剂之间做出明智的决策对于优化阿尔茨海默病管理中的患者结果至关重要.
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
T Cell Types and Functions
967
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
967
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


